Company · CIK 0000819050 · SIC 2836 — Biological Products, (No Diagnostic Substances)
VICAL INC · VICL
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 10, 2019 SForm 4 → | Jan 14, 5:52 pm EST | ARMISTICE CAPITAL, LLC +210% Owner | — | — | — | 2,170,000 | — | plan? |
| Jan 10, 2019 SForm 4 → | Jan 14, 5:52 pm EST | ARMISTICE CAPITAL, LLC +210% Owner | 2,190,500 | $0.8814 | $1,930,707 | 2,170,000 | −50.2% | plan? |
| Jun 28, 2018 PForm 4 → | Jul 2, 5:44 pm EDT | ARMISTICE CAPITAL, LLC +210% Owner | — | — | — | 4,360,500 | — | plan? |
| Jun 28, 2018 PForm 4 → | Jul 2, 5:44 pm EDT | ARMISTICE CAPITAL, LLC +210% Owner | 1,276,591 | $1.21 | $1,538,981 | 4,360,500 | +41.4% | plan? |
| Jun 25, 2018 PForm 4 → | Jun 27, 5:14 pm EDT | ARMISTICE CAPITAL, LLC +210% Owner | — | — | — | 3,083,909 | — | plan? |
| Jun 25, 2018 PForm 4 → | Jun 27, 5:14 pm EDT | ARMISTICE CAPITAL, LLC +210% Owner | 51,805 | $1.24 | $64,136 | 3,083,909 | +1.71% | plan? |
| Jun 20, 2018 PForm 4 → | Jun 22, 6:01 pm EDT | ARMISTICE CAPITAL, LLC +210% Owner | — | — | — | 3,032,104 | — | plan? |
| Jun 20, 2018 PForm 4 → | Jun 22, 6:01 pm EDT | ARMISTICE CAPITAL, LLC +210% Owner | 18,362 | $1.26 | $23,061 | 3,032,104 | +0.61% | plan? |
| Jun 14, 2018 PForm 4 → | Jun 18, 5:36 pm EDT | ARMISTICE CAPITAL, LLC +210% Owner | — | — | — | 3,013,742 | — | plan? |
| Jun 14, 2018 PForm 4 → | Jun 18, 5:36 pm EDT | ARMISTICE CAPITAL, LLC +210% Owner | 42,845 | $1.17 | $50,052 | 3,013,742 | +1.44% | plan? |
| Jun 11, 2018 PForm 4 → | Jun 13, 6:12 pm EDT | ARMISTICE CAPITAL, LLC +210% Owner | — | — | — | 2,970,897 | — | plan? |
| Jun 11, 2018 PForm 4 → | Jun 13, 6:12 pm EDT | ARMISTICE CAPITAL, LLC +210% Owner | 670,897 | $1.16 | $779,329 | 2,970,897 | +29.2% | plan? |
| Jan 22, 2018 PForm 4 → | Jan 26, 5:53 pm EST | ARMISTICE CAPITAL, LLC +210% Owner | — | — | — | 2,300,000 | — | plan? late |
| Jan 22, 2018 PForm 4 → | Jan 26, 5:53 pm EST | ARMISTICE CAPITAL, LLC +210% Owner | 100,000 | $1.43 | $143,025 | 2,300,000 | +4.55% | plan? late |
| Nov 10, 2017 PForm 4 → | Nov 14, 11:22 am EST | Robert C MertonDirector | 85,700 | $1.75 | $149,975 | 95,451 | +879% | plan? |
| Mar 27, 2017 SForm 4 → | Mar 28, 4:50 pm EDT | Anthony Alan RamosVP, Chief Accounting Officer | 4,250 | $2.17 | $9,240 | 9,674 | −30.5% | plan? |
| Mar 15, 2017 SForm 4 → | Mar 17, 4:43 pm EDT | Lawrence Russell SmithVP, Vaccine Research | 875 | $2.31 | $2,021 | 17,696 | −4.71% | plan? |
| Feb 10, 2017 SForm 4 → | Feb 14, 4:13 pm EST | Lawrence Russell SmithVP, Vaccine Research | 4,500 | $2.26 | $10,160 | 18,571 | −19.5% | plan? |
| Feb 1, 2017 SForm 4 → | Feb 3, 4:16 pm EST | Vijay B SamantPresident & CEO, Director | 3,750 | $2.16 | $8,088 | 87,420 | −4.11% | plan? |
| Jan 11, 2017 SForm 4 → | Jan 13, 4:17 pm EST | Lawrence Russell SmithVP, Vaccine Research | 54 | $2.48 | $134 | 23,071 | −0.23% | plan? |
| Jan 10, 2017 SForm 4 → | Jan 12, 4:24 pm EST | Vijay B SamantPresident & CEO, Director | 5,763 | $2.45 | $14,114 | 91,170 | −5.95% | plan? |
| Dec 21, 2016 SForm 4 → | Dec 22, 5:27 pm EST | Robert C MertonDirector | 4,000 | $2.24 | $8,960 | 9,751 | −29.1% | plan? |
| Dec 19, 2016 SForm 4 → | Dec 20, 5:58 pm EST | Robert C MertonDirector | 4,327 | $2.21 | $9,583 | 13,751 | −23.9% | plan? |
| Dec 12, 2016 SForm 4 → | Dec 13, 6:45 pm EST | Vijay B SamantPresident & CEO, Director | 15,699 | $2.39 | $37,588 | 96,933 | −13.9% | plan? |
| Dec 12, 2016 SForm 4 → | Dec 13, 5:27 pm EST | R Gordon DouglasDirector | 10,078 | $2.39 | $24,109 | 10,828 | −48.2% | plan? |
| Dec 5, 2016 SForm 4 → | Dec 7, 4:35 pm EST | Gary A LyonsDirector | 7,078 | $2.30 | $16,248 | 7,828 | −47.5% | plan? |
| Oct 11, 2016 SForm 4 → | Oct 12, 12:24 pm EDT | Lawrence Russell SmithVP, Vaccine Research | 54 | $3.05 | $165 | 23,125 | −0.23% | plan? |
| Jul 11, 2016 SForm 4 → | Jul 13, 1:25 pm EDT | Lawrence Russell SmithVP, Vaccine Research | 54 | $4.46 | $241 | 23,179 | −0.23% | plan? |
| Jun 13, 2016 PForm 4 → | Jun 14, 4:59 pm EDT | Robert C MertonDirector | 9,000 | $4.34 | $39,098 | 18,078 | +99.1% | plan? |
| Jun 9, 2016 PForm 4 → | Jun 10, 4:08 pm EDT | Vijay B SamantPresident & CEO, Director | 15,700 | $4.72 | $74,154 | 112,632 | +16.2% | plan? |
| Jun 6, 2016 PForm 4 → | Jun 8, 1:08 pm EDT | R Gordon DouglasDirector | 10,078 | $4.41 | $44,444 | 20,906 | +93.1% | plan? |
| Jun 3, 2016 PForm 4 → | Jun 6, 6:42 pm EDT | Gary A LyonsDirector | 7,078 | $4.39 | $31,089 | 14,906 | +90.4% | plan? |
| Mar 15, 2016 SForm 4 → | Mar 17, 3:33 pm EDT | Lawrence Russell SmithVP, Vaccine Research | 8,750 | $0.4095 | $3,583 | 232,331 | −3.63% | plan? |
| Mar 1, 2016 SForm 4 → | Mar 3, 5:21 pm EST | Vijay B SamantPresident & CEO, Director | 37,500 | $0.3615 | $13,556 | 969,326 | −3.72% | plan? |
| Feb 19, 2016 SForm 4 → | Feb 22, 2:39 pm EST | Anthony Alan RamosVP, Chief Accounting Officer | 7,500 | $0.3303 | $2,477 | 139,235 | −5.11% | plan? |
| Jan 25, 2016 SForm 4 → | Jan 26, 3:06 pm EST | Anthony Alan RamosVP, Chief Accounting Officer | 193 | $0.351 | $68 | 146,735 | −0.13% | plan? |
| Jan 11, 2016 SForm 4 → | Jan 13, 2:36 pm EST | Vijay B SamantPresident & CEO, Director | 59,737 | $0.3475 | $20,760 | 1,006,826 | −5.60% | plan? |
| Jan 11, 2016 SForm 4 → | Jan 13, 2:31 pm EST | Lawrence Russell SmithVP, Vaccine Research | 974 | $0.36 | $351 | 241,081 | −0.40% | plan? |
| Jan 7, 2016 SForm 4 → | Jan 8, 6:07 pm EST | Vijay B SamantPresident & CEO, Director | 75,000 | $0.3612 | $27,090 | 1,066,563 | −6.57% | plan? |
| Dec 18, 2015 AForm 4 → | Dec 22, 5:32 pm EST | Thomas E ShenkDirector | 10,000 | $0.01 | $100 | 10,000 | — | plan? |
| Oct 23, 2015 SForm 4 → | Oct 27, 12:37 pm EDT | Anthony Alan RamosVP, Chief Accounting Officer | 193 | $0.39 | $75 | 146,928 | −0.13% | plan? |
| Oct 12, 2015 SForm 4 → | Oct 14, 12:49 pm EDT | Lawrence Russell SmithVP, Vaccine Research | 974 | $0.426 | $415 | 242,055 | −0.40% | plan? |
| Oct 12, 2015 SForm 4 → | Oct 14, 12:46 pm EDT | Vijay B SamantPresident & CEO, Director | 4,738 | $0.414 | $1,962 | 1,141,563 | −0.41% | plan? |
| Jul 23, 2015 SForm 4 → | Jul 27, 1:24 pm EDT | Anthony Alan RamosVP, Chief Accounting Officer | 194 | $0.62 | $120 | 147,121 | −0.13% | plan? |
| Jul 13, 2015 SForm 4 → | Jul 15, 5:18 pm EDT | Lawrence Russell SmithVP, Vaccine Research | 974 | $0.6983 | $680 | 243,029 | −0.40% | plan? |
| Jul 13, 2015 SForm 4 → | Jul 15, 5:14 pm EDT | Vijay B SamantPresident & CEO, Director | 4,737 | $0.6987 | $3,310 | 1,146,301 | −0.41% | plan? |
| Jul 13, 2015 SForm 4 → | Jul 15, 4:49 pm EDT | Igor BilinskySr VP, Corporate Development | 1,258 | $0.6985 | $879 | 193,798 | −0.64% | plan? |
| May 21, 2015 AForm 4 → | May 26, 1:31 pm EDT | George J MorrowDirector | 7,500 | $0.01 | $75 | 27,347 | — | plan? |
| May 21, 2015 AForm 4 → | May 26, 1:25 pm EDT | Stephen A SherwinDirector | 7,500 | $0.01 | $75 | 22,003 | — | plan? |
| May 21, 2015 AForm 4 → | May 26, 1:20 pm EDT | Richard M BelesonDirector | 7,500 | $0.01 | $75 | 22,078 | — | plan? |
| May 21, 2015 AForm 4 → | May 26, 1:15 pm EDT | Gary A LyonsDirector | 7,500 | $0.01 | $75 | 78,281 | — | plan? |
| May 21, 2015 AForm 4 → | May 26, 1:12 pm EDT | Robert C MertonDirector | 7,500 | $0.01 | $75 | 90,781 | — | plan? |
| May 21, 2015 AForm 4 → | May 26, 1:06 pm EDT | R Gordon DouglasDirector | 7,500 | $0.01 | $75 | 108,281 | — | plan? |
| Apr 23, 2015 SForm 4 → | Apr 27, 12:18 pm EDT | Anthony Alan RamosVP, Chief Accounting Officer | 193 | $1.01 | $195 | 147,315 | −0.13% | plan? |
| Apr 13, 2015 SForm 4 → | Apr 15, 4:10 pm EDT | Vijay B SamantPresident & CEO, Director | 4,738 | $0.931 | $4,411 | 1,151,038 | −0.41% | plan? |
| Apr 13, 2015 SForm 4 → | Apr 15, 4:07 pm EDT | Lawrence Russell SmithVP, Vaccine Research | 974 | $0.9335 | $909 | 244,003 | −0.40% | plan? |
| Apr 13, 2015 SForm 4 → | Apr 15, 4:01 pm EDT | Igor BilinskySr VP, Corporate Development | 1,257 | $0.933 | $1,173 | 195,056 | −0.64% | plan? |
| Mar 30, 2015 SForm 4 → | Apr 1, 4:34 pm EDT | Vijay B SamantPresident & CEO, Director | 55,000 | $0.9118 | $50,149 | 1,155,776 | −4.54% | plan? |
| Jan 21, 2015 SForm 4 → | Jan 22, 5:20 pm EST | Anthony Alan RamosVP, Chief Accounting Officer | 428 | $1.09 | $467 | 147,508 | −0.29% | plan? |
| Jan 19, 2015 AForm 4 → | Jan 21, 7:56 pm EST | Anthony Alan RamosVP, Chief Accounting Officer | 60,000 | $0.01 | $600 | 147,936 | — | plan? |
| Jan 19, 2015 AForm 4 → | Jan 21, 7:54 pm EST | Igor BilinskySr VP, Corporate Development | 70,000 | $0.01 | $700 | 196,313 | — | plan? |
| Jan 19, 2015 AForm 4 → | Jan 21, 7:50 pm EST | Vijay B SamantPresident & CEO, Director | 300,000 | $0.01 | $3,000 | 1,210,776 | — | plan? |
| Jan 19, 2015 AForm 4 → | Jan 21, 7:19 pm EST | Lawrence Russell SmithVP, Vaccine Research | 70,000 | $0.01 | $700 | 244,977 | — | plan? |
| Jan 13, 2015 SForm 4 → | Jan 14, 1:29 pm EST | Vijay B SamantPresident & CEO, Director | 4,737 | $1.12 | $5,312 | 910,776 | −0.52% | plan? |
| Jan 12, 2015 SForm 4 → | Jan 14, 1:22 pm EST | Lawrence Russell SmithVP, Vaccine Research | 1,912 | $1.16 | $2,210 | 174,977 | −1.08% | plan? |
| Jan 12, 2015 SForm 4 → | Jan 14, 1:15 pm EST | Igor BilinskySr VP, Corporate Development | 1,335 | $1.16 | $1,544 | 126,313 | −1.05% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 18, 2018 AForm 4 → | Jun 19, 12:47 pm EDT | Vijay B SamantPresident & CEO, Director | 105,000 | — | — | 105,000 | — | |
| May 23, 2018 AForm 4 → | May 24, 11:40 am EDT | Robert C MertonDirector | 6,500 | — | — | 6,500 | — | |
| May 23, 2018 AForm 4 → | May 24, 11:36 am EDT | Richard M BelesonDirector | 6,500 | — | — | 6,500 | — | |
| May 23, 2018 AForm 4 → | May 24, 11:33 am EDT | George J MorrowDirector | 6,500 | — | — | 6,500 | — | |
| May 23, 2018 AForm 4 → | May 24, 11:30 am EDT | Gary A LyonsDirector | 6,500 | — | — | 6,500 | — | |
| May 23, 2018 AForm 4 → | May 24, 11:28 am EDT | R Gordon DouglasDirector | 8,000 | — | — | 8,000 | — | |
| May 23, 2018 AForm 4 → | May 24, 11:26 am EDT | Thomas E ShenkDirector | 6,500 | — | — | 6,500 | — | |
| Jan 8, 2018 AForm 4 → | Jan 10, 11:36 am EST | Vijay B SamantPresident & CEO, Director | 105,000 | — | — | 36,775 | — | |
| Jan 8, 2018 AForm 4 → | Jan 10, 11:29 am EST | Mammen MammenSr VP, Clinical Development | 70,000 | — | — | 12,842 | — | |
| Jan 8, 2018 AForm 4 → | Jan 10, 11:25 am EST | Anthony Alan RamosVP, Chief Financial Officer | 70,000 | — | — | 14,562 | — | |
| Jan 8, 2018 AForm 4 → | Jan 10, 11:05 am EST | Lawrence Russell SmithSr VP, Research | 60,000 | — | — | 8,467 | — | |
| May 25, 2017 AForm 4 → | May 31, 3:09 pm EDT | Thomas E ShenkDirector | 6,500 | — | — | 6,500 | — | late |
| May 25, 2017 AForm 4 → | May 30, 6:50 pm EDT | R Gordon DouglasDirector | 8,000 | — | — | 8,000 | — | |
| May 25, 2017 AForm 4 → | May 30, 6:32 pm EDT | Mammen MammenSr VP, Clinical Development | 10,000 | — | — | 10,000 | — | |
| May 25, 2017 AForm 4 → | May 30, 6:27 pm EDT | Richard M BelesonDirector | 6,500 | — | — | 6,500 | — | |
| May 25, 2017 AForm 4 → | May 30, 6:23 pm EDT | George J MorrowDirector | 6,500 | — | — | 6,500 | — | |
| May 25, 2017 AForm 4 → | May 30, 5:43 pm EDT | Robert C MertonDirector | 6,500 | — | — | 6,500 | — | |
| May 25, 2017 AForm 4 → | May 30, 5:40 pm EDT | Gary A LyonsDirector | 6,500 | — | — | 6,500 | — | |
| May 25, 2017 AForm 4 → | May 30, 5:30 pm EDT | Anthony Alan RamosVP, Chief Financial Officer | 10,000 | — | — | 10,000 | — | |
| May 25, 2017 AForm 4 → | May 30, 5:25 pm EDT | Lawrence Russell SmithSr VP, Research | 10,000 | — | — | 10,000 | — | |
| May 25, 2017 AForm 4 → | May 30, 5:20 pm EDT | Vijay B SamantPresident & CEO, Director | 25,000 | — | — | 25,000 | — | |
| Jan 12, 2017 AForm 4 → | Jan 17, 2:15 pm EST | Vijay B SamantPresident & CEO, Director | 130,000 | — | — | 80,000 | — | |
| Jan 12, 2017 AForm 4 → | Jan 17, 2:09 pm EST | Lawrence Russell SmithVP, Vaccine Research | 45,000 | — | — | 20,000 | — | |
| Jan 12, 2017 AForm 4 → | Jan 17, 2:03 pm EST | Anthony Alan RamosVP, Chief Accounting Officer | 45,000 | — | — | 20,000 | — | |
| May 20, 2016 AForm 4 → | May 24, 12:13 pm EDT | Vijay B SamantPresident & CEO, Director | 212,500 | — | — | 212,500 | — | |
| May 20, 2016 AForm 4 → | May 24, 11:32 am EDT | R Gordon DouglasDirector | 80,000 | — | — | 80,000 | — | |
| May 20, 2016 AForm 4 → | May 24, 11:27 am EDT | Gary A LyonsDirector | 65,000 | — | — | 65,000 | — | |
| May 20, 2016 AForm 4 → | May 24, 11:24 am EDT | George J MorrowDirector | 65,000 | — | — | 65,000 | — | |
| May 20, 2016 AForm 4 → | May 24, 11:23 am EDT | Robert C MertonDirector | 65,000 | — | — | 65,000 | — | |
| May 20, 2016 AForm 4 → | May 24, 11:13 am EDT | Richard M BelesonDirector | 65,000 | — | — | 65,000 | — | |
| May 20, 2016 AForm 4 → | May 24, 10:57 am EDT | Thomas E ShenkDirector | 65,000 | — | — | 65,000 | — | |
| Jan 15, 2016 AForm 4 → | Jan 15, 6:43 pm EST | Vijay B SamantPresident & CEO, Director | 425,000 | — | — | 425,000 | — | |
| Jan 15, 2016 AForm 4 → | Jan 15, 6:40 pm EST | Anthony Alan RamosVP, Chief Accounting Officer | 300,000 | — | — | 300,000 | — | |
| Jan 15, 2016 AForm 4 → | Jan 15, 6:35 pm EST | Lawrence Russell SmithVP, Vaccine Research | 250,000 | — | — | 250,000 | — | |
| Dec 18, 2015 AForm 4 → | Dec 22, 5:32 pm EST | Thomas E ShenkDirector | 60,000 | — | — | 60,000 | — | |
| May 21, 2015 AForm 4 → | May 26, 1:31 pm EDT | George J MorrowDirector | 50,000 | — | — | 50,000 | — | |
| May 21, 2015 AForm 4 → | May 26, 1:25 pm EDT | Stephen A SherwinDirector | 50,000 | — | — | 50,000 | — | |
| May 21, 2015 AForm 4 → | May 26, 1:20 pm EDT | Richard M BelesonDirector | 50,000 | — | — | 50,000 | — | |
| May 21, 2015 AForm 4 → | May 26, 1:15 pm EDT | Gary A LyonsDirector | 50,000 | — | — | 50,000 | — | |
| May 21, 2015 AForm 4 → | May 26, 1:12 pm EDT | Robert C MertonDirector | 50,000 | — | — | 50,000 | — | |
| May 21, 2015 AForm 4 → | May 26, 1:06 pm EDT | R Gordon DouglasDirector | 65,000 | — | — | 65,000 | — | |
| May 21, 2015 AForm 4 → | May 26, 12:28 pm EDT | Vijay B SamantPresident & CEO, Director | 125,000 | — | — | 125,000 | — | |
| Jan 19, 2015 AForm 4 → | Jan 21, 7:56 pm EST | Anthony Alan RamosVP, Chief Accounting Officer | 100,000 | — | — | 100,000 | — | |
| Jan 19, 2015 AForm 4 → | Jan 21, 7:54 pm EST | Igor BilinskySr VP, Corporate Development | 140,000 | — | — | 140,000 | — | |
| Jan 19, 2015 AForm 4 → | Jan 21, 7:50 pm EST | Vijay B SamantPresident & CEO, Director | 250,000 | — | — | 250,000 | — | |
| Jan 19, 2015 AForm 4 → | Jan 21, 7:19 pm EST | Lawrence Russell SmithVP, Vaccine Research | 120,000 | — | — | 120,000 | — |